Trademark: 79148311
Status Date
Friday, May 21, 2021
Registration Number
4630484
Registration Date
Tuesday, November 4, 2014
Filing Date
Thursday, April 3, 2014
Published for Opposition
Tuesday, August 19, 2014
Cancellation Date
Friday, May 21, 2021
5 Pharmaceutical products, namely, products derived from blood plasma, particularly immunoglobulin
Jul 18, 2022
Total Invalidation Processed By The Ib
May 18, 2022
Total Invalidation Of Reg Ext Protection Sent To Ib
May 18, 2022
Invalidation Processed
Jan 21, 2022
Total Invalidation Of Reg Ext Protection Created
May 21, 2021
Cancelled Section 71
Aug 18, 2016
New Representative At Ib Received
Aug 11, 2016
New Representative At Ib Received
Aug 11, 2016
New Representative At Ib Received
Mar 13, 2015
Notification Processed By Ib
Feb 23, 2015
Final Disposition Notice Sent To Ib
Feb 23, 2015
Final Disposition Processed
Dec 4, 2014
Grant Of Protection Created, To Be Sent To Ib
Nov 4, 2014
Registered-Principal Register
Sep 4, 2014
New Representative At Ib Received
Aug 19, 2014
Published For Opposition
Jul 30, 2014
Notice Of Publication
Jul 11, 2014
Approved For Pub - Principal Register
Jul 11, 2014
Assigned To Examiner
Jul 1, 2014
Application Filing Receipt Mailed
Jun 27, 2014
New Application Office Supplied Data Entered In Tram
Jun 26, 2014
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
